Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with Β-interferon 1a (avonex).]
Apitope starts new clinical trial of its investigational Multiple Sclerosis treatment
Treatment with interferon beta for multiple sclerosis.
Can the ABILHAND handle manual ability in MS?
Progesterone alleviates neural behavioral deficits and demyelination with reduced degeneration of oligodendroglial cells in cuprizone-induced mice.
[Disruption of the blood-brain barrier in inflammatory neurological diseases].
Reproduction and the risk of multiple sclerosis.
Up-Regulation of Excitatory Amino Acid Transporters EAAT1 and EAAT2 by ß-Klotho.
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
Erythromelalgia-like presentation of chronic acquired demyelinating polyneuropathy in a setting of past alcohol abuse.
Efficacy and safety of cutting balloons for the treatment of obstructive lesions in the internal jugular veins.
A pervasive assessment of motor function: a lightweight grip strength tracking system.
Age of Onset as a Moderator of Cognitive Decline in Pediatric-Onset Multiple Sclerosis.
Effect of short-term interferon-β treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23.
Vitamin d and multiple sclerosis.
[Optic Neuritis.]
Transcriptional expression of MBP in oligodendrocytes depends on functional syntaxin 4; a potential correlation with autocrine signalling.
Demyelinating disease: Is TOPIC the last trial for clinically isolated syndrome?
Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings.
Axial 3D gradient-echo imaging for improved multiple sclerosis lesion detection in the cervical spinal cord at 3T.
Usability and Potential of Geostatistics for Spatial Discrimination of Multiple Sclerosis Lesion Patterns.
Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012).
Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis mice.
Accelerometry Reveals Differences in Gait Variability Between Patients with Multiple Sclerosis and Healthy Controls.
Increased Concentrations of Glutamate and Glutamine in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans.

Pages